Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Leukotriene A4 Hydrolase Activation and Leukotriene B4 Production by Eosinophils in Severe Asthma.

Pal K, Feng X, Steinke JW, Burdick MD, Shim YM, Sung SS, Teague WG, Borish L.

Am J Respir Cell Mol Biol. 2019 Apr;60(4):413-419. doi: 10.1165/rcmb.2018-0175OC.

PMID:
30352167
2.

Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease.

Mehrad B, Burdick MD, Wandersee NJ, Shahir KS, Zhang L, Simpson PM, Strieter RM, Field JJ.

Blood Adv. 2017 Nov 6;1(24):2217-2224. doi: 10.1182/bloodadvances.2017010777. eCollection 2017 Nov 14.

3.

Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia.

Michels KR, Zhang Z, Bettina AM, Cagnina RE, Stefanova D, Burdick MD, Vaulont S, Nemeth E, Ganz T, Mehrad B.

JCI Insight. 2017 Mar 23;2(6):e92002. doi: 10.1172/jci.insight.92002.

4.

M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes.

Bettina A, Zhang Z, Michels K, Cagnina RE, Vincent IS, Burdick MD, Kadl A, Mehrad B.

J Immunol. 2016 Jun 15;196(12):5047-55. doi: 10.4049/jimmunol.1600306. Epub 2016 May 4.

5.

Circulating fibrocytes as predictors of adverse events in unstable angina.

Keeley EC, Schutt RC, Marinescu MA, Burdick MD, Strieter RM, Mehrad B.

Transl Res. 2016 Jun;172:73-83.e1. doi: 10.1016/j.trsl.2016.02.013. Epub 2016 Mar 8.

6.

Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity.

Schutte KM, Fisher DJ, Burdick MD, Mehrad B, Mathers AJ, Mann BJ, Nakamoto RK, Hughes MA.

Infect Immun. 2015 Nov 9;84(1):320-8. doi: 10.1128/IAI.00552-15. Print 2016 Jan.

7.

Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity.

Shipe R, Burdick MD, Strieter BA, Liu L, Shim YM, Sung SS, Teague WG, Mehrad B, Strieter RM, Rose CE Jr.

J Allergy Clin Immunol. 2016 Mar;137(3):750-7.e3. doi: 10.1016/j.jaci.2015.07.037. Epub 2015 Sep 12.

8.

Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome.

Trimble A, Gochuico BR, Markello TC, Fischer R, Gahl WA, Lee JK, Kim Y, Burdick MD, Strieter RM, Mehrad B.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1395-401. doi: 10.1164/rccm.201407-1287OC.

9.

Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors.

Chen L, Zhang Z, Barletta KE, Burdick MD, Mehrad B.

Am J Physiol Lung Cell Mol Physiol. 2013 Nov 15;305(10):L702-11. doi: 10.1152/ajplung.00194.2013. Epub 2013 Sep 20.

10.

CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.

Choi YH, Burdick MD, Strieter BA, Mehrad B, Strieter RM.

Mol Cancer Res. 2014 Jan;12(1):38-47. doi: 10.1158/1541-7786.MCR-12-0334. Epub 2013 Sep 11.

11.

Dose-dependent Effect of Statin Therapy on Circulating CXCL12 Levels in Patients with Hyperlipidemia.

Camnitz W, Burdick MD, Strieter RM, Mehrad B, Keeley EC.

Clin Transl Med. 2012 Oct 6;1(1):23. doi: 10.1186/2001-1326-1-23.

12.

Plasma CXCL12 levels as a predictor of future stroke.

Schutt RC, Burdick MD, Strieter RM, Mehrad B, Keeley EC.

Stroke. 2012 Dec;43(12):3382-6. doi: 10.1161/STROKEAHA.112.660878. Epub 2012 Oct 4.

13.

Adenosine A(2B) receptor deficiency promotes host defenses against gram-negative bacterial pneumonia.

Barletta KE, Cagnina RE, Burdick MD, Linden J, Mehrad B.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):1044-50. doi: 10.1164/rccm.201204-0622OC. Epub 2012 Sep 20.

14.

The role of fibrocytes in sickle cell lung disease.

Field JJ, Burdick MD, DeBaun MR, Strieter BA, Liu L, Mehrad B, Rose CE Jr, Linden J, Strieter RM.

PLoS One. 2012;7(3):e33702. doi: 10.1371/journal.pone.0033702. Epub 2012 Mar 19.

15.

Neutrophils mediate maturation and efflux of lung dendritic cells in response to Aspergillus fumigatus germ tubes.

Park SJ, Burdick MD, Mehrad B.

Infect Immun. 2012 May;80(5):1759-65. doi: 10.1128/IAI.00097-12. Epub 2012 Mar 5.

16.

Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype.

Paige M, Burdick MD, Kim S, Xu J, Lee JK, Shim YM.

Biochem Biophys Res Commun. 2011 Oct 7;413(4):588-93. doi: 10.1016/j.bbrc.2011.09.006. Epub 2011 Sep 8.

17.

Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker.

LaPar DJ, Burdick MD, Emaminia A, Harris DA, Strieter BA, Liu L, Robbins M, Kron IL, Strieter RM, Lau CL.

Ann Thorac Surg. 2011 Aug;92(2):470-7; discussion 477. doi: 10.1016/j.athoracsur.2011.04.065.

18.

Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease.

Keeley EC, Moorman JR, Liu L, Gimple LW, Lipson LC, Ragosta M, Taylor AM, Lake DE, Burdick MD, Mehrad B, Strieter RM.

PLoS One. 2011;6(6):e21174. doi: 10.1371/journal.pone.0021174. Epub 2011 Jun 22.

19.

Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.

Crawford MA, Burdick MD, Glomski IJ, Boyer AE, Barr JR, Mehrad B, Strieter RM, Hughes MA.

PLoS Pathog. 2010 Nov 18;6(11):e1001199. doi: 10.1371/journal.ppat.1001199.

20.

Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.

Struyf S, Salogni L, Burdick MD, Vandercappellen J, Gouwy M, Noppen S, Proost P, Opdenakker G, Parmentier M, Gerard C, Sozzani S, Strieter RM, Van Damme J.

Blood. 2011 Jan 13;117(2):480-8. doi: 10.1182/blood-2009-11-253591. Epub 2010 Oct 27.

21.

Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.

Dengel LT, Norrod AG, Gregory BL, Clancy-Thompson E, Burdick MD, Strieter RM, Slingluff CL Jr, Mullins DW.

J Immunother. 2010 Nov-Dec;33(9):965-74. doi: 10.1097/CJI.0b013e3181fb045d.

22.

Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-to-chemokine amplification loop.

Park SJ, Burdick MD, Brix WK, Stoler MH, Askew DS, Strieter RM, Mehrad B.

J Immunol. 2010 Nov 15;185(10):6190-7. doi: 10.4049/jimmunol.1002064. Epub 2010 Oct 6.

23.

Role of LTB₄ in the pathogenesis of elastase-induced murine pulmonary emphysema.

Shim YM, Paige M, Hanna H, Kim SH, Burdick MD, Strieter RM.

Am J Physiol Lung Cell Mol Physiol. 2010 Dec;299(6):L749-59. doi: 10.1152/ajplung.00116.2010. Epub 2010 Sep 3.

24.

Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes.

Choi YH, Burdick MD, Strieter RM.

Int J Biochem Cell Biol. 2010 May;42(5):662-71. doi: 10.1016/j.biocel.2009.12.011. Epub 2009 Dec 23.

25.

The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.

Strieter RM, Keeley EC, Burdick MD, Mehrad B.

Trans Am Clin Climatol Assoc. 2009;120:49-59. Review.

26.

The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis.

Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B.

J Leukoc Biol. 2009 Nov;86(5):1111-8. doi: 10.1189/jlb.0309132. Epub 2009 Jul 6. Review.

27.

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.

Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM.

BMC Cancer. 2009 Jun 29;9:213. doi: 10.1186/1471-2407-9-213.

28.

Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.

Mehrad B, Burdick MD, Strieter RM.

Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1708-18. doi: 10.1016/j.biocel.2009.02.020. Epub 2009 Mar 6.

29.

CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.

Matsuo Y, Raimondo M, Woodward TA, Wallace MB, Gill KR, Tong Z, Burdick MD, Yang Z, Strieter RM, Hoffman RM, Guha S.

Int J Cancer. 2009 Sep 1;125(5):1027-37. doi: 10.1002/ijc.24383.

30.

CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis.

Busuttil A, Weigt SS, Keane MP, Xue YY, Palchevskiy V, Burdick MD, Huang C, Zisman DA, Fishbein M, Lynch JP 3rd, Strieter RM, Elashoff RM, Belperio JA.

Eur Respir J. 2009 Sep;34(3):676-86. doi: 10.1183/09031936.00157508. Epub 2009 Apr 22.

31.

Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.

Crawford MA, Zhu Y, Green CS, Burdick MD, Sanz P, Alem F, O'Brien AD, Mehrad B, Strieter RM, Hughes MA.

Infect Immun. 2009 Apr;77(4):1664-78. doi: 10.1128/IAI.01208-08. Epub 2009 Jan 29.

32.

Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.

Struyf S, Burdick MD, Peeters E, Van den Broeck K, Dillen C, Proost P, Van Damme J, Strieter RM.

Cancer Res. 2007 Jun 15;67(12):5940-8.

33.

Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma.

Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM.

J Biol Chem. 2007 Aug 3;282(31):22910-20. Epub 2007 Jun 7.

34.

Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy.

Reckamp KL, Figlin RA, Moldawer N, Pantuck AJ, Belldegrun AS, Burdick MD, Strieter RM.

J Immunother. 2007 May-Jun;30(4):417-24.

PMID:
17457216
35.

Keratinocyte growth factor improves repair in the injured tracheal epithelium.

Gomperts BN, Belperio JA, Fishbein MC, Keane MP, Burdick MD, Strieter RM.

Am J Respir Cell Mol Biol. 2007 Jul;37(1):48-56. Epub 2007 Mar 1.

36.

Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa.

Godaly G, Otto G, Burdick MD, Strieter RM, Svanborg C.

Kidney Int. 2007 Apr;71(8):778-86. Epub 2007 Jan 17.

37.

Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease.

Mohsenin A, Burdick MD, Molina JG, Keane MP, Blackburn MR.

FASEB J. 2007 Apr;21(4):1026-36. Epub 2007 Jan 16.

PMID:
17227950
38.

IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.

Keane MP, Gomperts BN, Weigt S, Xue YY, Burdick MD, Nakamura H, Zisman DA, Ardehali A, Saggar R, Lynch JP 3rd, Hogaboam C, Kunkel SL, Lukacs NW, Ross DJ, Grusby MJ, Strieter RM, Belperio JA.

J Immunol. 2007 Jan 1;178(1):511-9.

39.

Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease.

Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM.

Biochem Biophys Res Commun. 2007 Feb 2;353(1):104-8. Epub 2006 Dec 11.

PMID:
17174272
40.

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.

Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM.

Mol Cancer. 2006 Nov 3;5:56.

41.

High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.

Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR, Tang H, Burdick MD, Sato M, Minna JD, Mao L, Wistuba I, Strieter RM, Kurie JM.

Cancer Res. 2006 Apr 15;66(8):4198-207.

42.

Cancer CXC chemokine networks and tumour angiogenesis.

Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA.

Eur J Cancer. 2006 Apr;42(6):768-78. Epub 2006 Feb 28. Review.

PMID:
16510280
43.

Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.

Wente MN, Keane MP, Burdick MD, Friess H, Büchler MW, Ceyhan GO, Reber HA, Strieter RM, Hines OJ.

Cancer Lett. 2006 Sep 28;241(2):221-7. Epub 2006 Feb 3.

PMID:
16458421
44.

Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury.

Gomperts BN, Belperio JA, Rao PN, Randell SH, Fishbein MC, Burdick MD, Strieter RM.

J Immunol. 2006 Feb 1;176(3):1916-27.

45.

CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis.

Pan J, Burdick MD, Belperio JA, Xue YY, Gerard C, Sharma S, Dubinett SM, Strieter RM.

J Immunol. 2006 Feb 1;176(3):1456-64.

46.

Clearance of prions during plasma protein manufacture.

Burdick MD, Pifat DY, Petteway SR Jr, Cai K.

Transfus Med Rev. 2006 Jan;20(1):57-62.

PMID:
16373188
47.

Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.

Jassar AS, Suzuki E, Kapoor V, Sun J, Silverberg MB, Cheung L, Burdick MD, Strieter RM, Ching LM, Kaiser LR, Albelda SM.

Cancer Res. 2005 Dec 15;65(24):11752-61.

48.

CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury.

Belperio JA, Keane MP, Burdick MD, Gomperts BN, Xue YY, Hong K, Mestas J, Zisman D, Ardehali A, Saggar R, Lynch JP 3rd, Ross DJ, Strieter RM.

J Immunol. 2005 Nov 15;175(10):6931-9.

49.

The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma.

Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM.

J Immunol. 2005 Oct 15;175(8):5351-7.

50.

Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice.

Hong KM, Burdick MD, Phillips RJ, Heber D, Strieter RM.

FASEB J. 2005 Dec;19(14):2029-31. Epub 2005 Sep 27.

PMID:
16188961

Supplemental Content

Loading ...
Support Center